Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension
Runikhina, N.K.; Tkacheva, O.N.
Kardiologiia 48(9): 50-52
2008
ISSN/ISBN: 0022-9040 PMID: 18991821 Document Number: 622737
Document emailed within 1 workday
Related Documents
Striuk, R.I.; Brytkova, I.V.; Bukhonkina, I.M.; Pavlova, L.N. 2008: Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol Kardiologiia 48(4): 29-33Hergueta García de Guadiana, G.; Paumard Fraguas, A. 1989: Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension Anales de Medicina Interna 6(1): 15-18
Escudero, J.; Hernandez, H. 1991: Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension International Journal of Clinical Pharmacology Research 11(5): 243-246
Ageev, F.T.; Deev, A.D. 2009: The use of felodipine in ambulatory practice: assessment of clinical efficacy and compliance in patients with arterial hypertension Kardiologiia 49(1): 30-33
Nayler, W.G.; Gu, X.H. 1991: The unique binding properties of amlodipine: a long-acting calcium antagonist Journal of Human Hypertension 5(Suppl 1): 55-59
Säfholm, C.; Havu, N. 1993: General toxicity of the new calcium antagonist felodipine in dogs Arzneimittel-Forschung 43(7): 729-733
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Gómez Huelgas, R. 1997: Diabetes and arterial hypertension: what calcium antagonist to choose? Anales de Medicina Interna 14(11): 594-595
Bellisi, M.; Castellini, E.; Trama, P.A.; Damiano, A.; Rizza, S.; Stella, C.; Cortese, E. 1998: Calcium antagonist vs diuretics. Doppler velocimetric monitoring of the carotid flow in patients with essential hypertension Minerva Cardioangiologica 46(1-2): 9-14
Forette, F.; Bellet, M.; Henry, J.F.; Hervy, M.P.; Poyard-Salmeron, C.; Bouchacourt, P. 1984: Treatment of arterial hypertension in the aged with a calcium antagonist: nicardipine Archives des Maladies du Coeur et des Vaisseaux 77(11): 1242-1246
Fagan, T.C.; Haggert, B.E.; Liss, C. 1994: Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension Clinical Therapeutics 16(4): 634-646
Linari, F.; Bruno, M.; Marangella, M. 1988: The role of calcium in essential arterial hypertension Minerva Urologica e Nefrologica 40(3): 201-205
Brun, J.; Fröberg, L.; Kronmann, P.; Olsson, L.B.; Skoog, P.; Tygesen, G.; Bengtsson, C.; Scherstén, B.; Tibblin, G. 1990: Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group Journal of Cardiovascular Pharmacology 15(Suppl 4): S60-S64
Baliakina, E.V.; Atakhanov, S.E.; Gabbasov, Z.A.; Popov, E.G.; Iurenev, A.P. 1992: The effect of long-term therapy with a calcium antagonist on thrombocyte function in hypertension patients Terapevticheskii Arkhiv 64(8): 39-43
Papi, L.; Ballestra, A.M.; Tomei, G.; Filice, M.; Giustarini, C. 1981: Evaluation of the efficacy of indapamide in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 26(11): 1585-1588
Khosseĭn, A.; Mukharliamov, N.M.; Mareev, V.I.; Lobova, N.M.; Ageev, F.T. 1988: Long-term use of the calcium antagonist nifedipine (corinfar) in the treatment of patients with primary pulmonary hypertension Kardiologiia 28(4): 54-58
Sluiter, H.E.; Wetzels, J.F.; Huysmans, F.T.; Koene, R.A. 1987: The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin Ii in normotensive volunteers Journal of Cardiovascular Pharmacology 10(Suppl 10): S154-S161
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Tosti-Croce, C.; Mantellini, R.; Fanti, P.; Sciarra, F. 1983: Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension Minerva Medica 74(14-15): 791-797
Ueno, H.; Takata, M.; Oh-hashi, S.; Tomoda, F.; Yasumoto, K.; Iida, H.; Sasayama, S. 1993: Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril Journal of Human Hypertension 7(2): 125-130